CLEC-2I Inhibitors
CLEC-2I inhibitors are chemical compounds that specifically target and block the function of CLEC-2I, a member of the C-type lectin receptor family involved in immune cell recognition and signaling. CLEC-2I, like other C-type lectin-like receptors, plays a role in recognizing specific molecular patterns on the surfaces of cells or pathogens, particularly carbohydrate structures. These receptors are part of the immune system's pattern recognition mechanism, helping immune cells identify foreign particles or damaged cells. CLEC-2I is likely involved in mediating interactions between immune cells and other cell types, facilitating responses that regulate immune function. By inhibiting CLEC-2I, these compounds block the receptor's ability to bind its ligands, preventing the activation of downstream signaling pathways associated with immune cell activation, migration, or cellular communication.
The inhibition of CLEC-2I occurs through various mechanisms depending on the design of the inhibitor. Some CLEC-2I inhibitors might bind directly to the carbohydrate recognition domain of the receptor, thereby obstructing its ability to interact with glycan ligands. Other inhibitors may act on intracellular domains responsible for signal transduction, disrupting the receptor's capacity to trigger downstream signaling pathways. Inhibition of CLEC-2I provides a valuable tool for researchers to study the receptor's function in immune modulation and cellular communication. By blocking CLEC-2I, scientists can explore how this receptor contributes to immune cell behavior, such as recognizing and responding to environmental signals. Investigating the effects of CLEC-2I inhibition enhances the understanding of how C-type lectin receptors help regulate immune responses and maintain cellular homeostasis across different tissues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin acts as a direct inhibitor of CLEC-2I by disrupting its natural killer cell lectin-like receptor binding activity. This interference prevents the interaction with ligands, inhibiting CLEC-2I function in immune responses. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide serves as a direct inhibitor of CLEC-2I by modulating actin filament polymerization. This interference disrupts the downstream processes influenced by CLEC-2I, affecting the T cell receptor signaling pathway and cellular actin dynamics. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as a direct inhibitor of CLEC-2I by influencing the regulation of interleukin-2 production. This interference disrupts the downstream processes affected by CLEC-2I, leading to altered interleukin-2 production and modulation of immune responses. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D serves as a direct inhibitor of CLEC-2I by disrupting actin filament polymerization. This interference affects the processes influenced by CLEC-2I, including the regulation of interleukin-2 production and T cell receptor signaling pathway, modulating immune responses. | ||||||
Piceatannol | 10083-24-6 | sc-200610 sc-200610A sc-200610B | 1 mg 5 mg 25 mg | $51.00 $71.00 $199.00 | 11 | |
Piceatannol acts as a direct inhibitor of CLEC-2I by influencing the T cell receptor signaling pathway. This interference disrupts downstream processes, altering actin filament polymerization and interleukin-2 production, modulating the immune responses influenced by CLEC-2I. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A serves as a direct inhibitor of CLEC-2I by modulating actin filament polymerization. This interference disrupts the downstream processes influenced by CLEC-2I, affecting the T cell receptor signaling pathway and regulation of interleukin-2 production, modulating immune responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 acts as a direct inhibitor of CLEC-2I by influencing the regulation of interleukin-2 production. This interference disrupts the downstream processes affected by CLEC-2I, leading to altered interleukin-2 production and modulation of immune responses. | ||||||